Press Release

ACE Inhibitors Market to Grow with a CAGR of 5.25% through 2029

Growing prevalence of cardiovascular diseases and Increased awareness of hypertension are factors driving the Global ACE Inhibitors Market in the forecast period 2025-2029


According to TechSci Research report, “ACE Inhibitors Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029F”, the Global ACE Inhibitors Market stood at USD 6.44 Billion in 2023 and is anticipated to grow with a CAGR of 5.25% through 2029The ACE Inhibitors Market is a vital component of the pharmaceutical industry, specializing in the treatment of cardiovascular diseases, primarily hypertension and heart failure. These medications lower blood pressure by relaxing blood vessels and reducing the heart's workload. This market overview explores the key drivers, applications, and competitive landscape of the ACE Inhibitors Market. Cardiovascular diseases, including hypertension, coronary artery disease, and heart failure, are increasing globally, creating a growing demand for effective treatments, with ACE inhibitors playing a crucial role in addressing this healthcare challenge.

The aging global population is a significant driver of the ACE Inhibitors Market, as age-related conditions like hypertension and heart disease become more prevalent. Increased public awareness of the risks associated with hypertension and the benefits of effective blood pressure control has led to higher diagnosis rates and a larger pool of potential patients for ACE inhibitors. Ongoing improvements in healthcare infrastructure worldwide have facilitated better diagnosis and treatment of cardiovascular diseases, further supporting the growth of the ACE Inhibitors Market. ACE inhibitors are widely used for managing hypertension, heart failure, and post-heart attack care, making them a critical component in these therapeutic regimens. Additionally, ACE inhibitors have demonstrated efficacy in slowing the progression of kidney disease in diabetic patients, particularly those with diabetic nephropathy.

 

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global ACE Inhibitors Market


The Global ACE Inhibitors Market is segmented into type, drug, dosage form, application, end user, region, and company

Based on drug, Ramipril dominated the Global ACE Inhibitors Market. This category includes medications like Enalapril and Lisinopril. This is ascribed due to proven efficacy in managing hypertension, heart failure, and diabetic nephropathy; extensive clinical research supporting its safety and effectiveness; favorable dosing regimen with once-daily administration; and broad acceptance in clinical guidelines. Additionally, Ramipril's availability in various formulations and generics ensures affordability and accessibility for patients worldwide. Its established reputation as a first-line therapy for cardiovascular conditions and its well-tolerated profile contribute to Ramipril's dominance in the ACE inhibitors market.

Based on application, hypertension dominated the Global ACE inhibitors Market. This is ascribed due to prevalence is attributed to several factors: it affects a significant portion of the global population, often remains asymptomatic, and is a major risk factor for various cardiovascular complications, including heart failure, chronic kidney disease, and heart attack. Moreover, hypertension is manageable through lifestyle modifications and pharmacotherapy, making it a focal point for preventive healthcare initiatives and treatment interventions worldwide. Its pervasive impact on public health and the healthcare system solidifies hypertension's dominance among cardiovascular conditions.

Based on region, The North America region has emerged as the fastest-growing segment in the ACE Inhibitors Market. This is ascribed due to the region's high prevalence of cardiovascular diseases, including hypertension and heart failure, drives substantial demand for ACE inhibitors. The robust healthcare infrastructure, advanced diagnostic capabilities, and widespread access to healthcare services ensure the effective diagnosis and management of cardiovascular conditions, promoting the use of ACE inhibitors as first-line therapies. The extensive clinical research and pharmaceutical innovation in North America have led to the development of ACE inhibitors with proven efficacy and safety profiles, reinforcing their market dominance in the region.


Major companies operating in Global ACE Inhibitors Market are:

  • Pfizer Inc
  • Novartis AG
  • Johnson & Johnson
  • Merck KGaA
  • Sanofi S.A
  • Bayer AG
  • United Therapeutics Corporation
  • Teva Pharmaceutical Industry
  • Bristol-Myers Squibb
  • Takeda Pharmaceuticals Company

 

Download Free Sample Report

 Customers can also request 10% free customization on this report


“The future of the ACE Inhibitors Market is promising, driven by ongoing advancements in healthcare, increasing cardiovascular disease burdens, and evolving treatment approaches. As research and development continue to focus on more targeted and innovative ACE inhibitors, patients will benefit from improved therapeutic options with reduced side effects. Personalized medicine will play a more prominent role, ensuring tailored treatments for individual patients. Furthermore, the adoption of telemedicine and digital healthcare will enhance accessibility and adherence. With the aging global population and rising awareness of hypertension, the demand for ACE inhibitors is expected to remain high. The market's future holds a wealth of opportunities for pharmaceutical companies to innovate and meet the evolving needs of patients”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

ACE Inhibitors Market By Type (Sulfhydryl-containing Agents, Dicarboxylate-containing Agents, Phosphonate-containing Agents), By Drug (Ramipril, Enalapril, Benazepril, Fosinopril, Captopril, Moexipril, Others), By Dosage Form (Oral Tablets, Oral Solutions), By Application (Heart Failure, Chronic Kidney Disease, Hypertension, Diabetes, Heart Attack, Others), By End user (Hospitals, Online Drug Stores, Others), By Region, By Competition Forecast & Opportunities, 2019-2029F”, has evaluated the future growth potential of Global ACE Inhibitors Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global ACE Inhibitors Market.


Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com

Relevant News